Study for Novel Coronavirus Pneumonia (NCP)

• Conditions: Novel Coronavirus Pneumonia

• Registration Number: NCT04283396
• Lead Sponsor: Wuhan Union Hospital, China

Brief Summary

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

Detailed Description

By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic.

Study Timeline

• Study First Submitted: 2020-02-13
• Study First Submitted QC: 2020-02-20
• Study Start: 2020-02-21
• Study First Posted: 2020-02-25
• Status Verified: 2020-03
• Last Update Submitted: 2020-03-15
• Last Update Posted: 2020-03-17
• Primary Completion: 2020-05-30
• Study Completion: 2020-07-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial Version 5)";

Exclusion Criteria

• Physician judged the patient was not suitable for this clinical trial.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
recovery	up to 24 weeks	Number of patients recover from novel coronavirus pneumonia

Trial Locations

Locations (1)

Union hospital; 🇨🇳 Wuhan, Hubei, China